Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives — Masatoshi Kudo (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Shared by
Masatoshi Kudo
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Editorial Material
2016
en
Authors
Masatoshi Kudo
Related publications
Article
2023
[Management of hepatocellular carcinoma: current status and future perspective].
Masatoshi Kudo
Editorial Material
2019
Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma
Masatoshi Kudo
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2003
Hepatocellular carcinoma: present status and future prospects
Josep M. Llovet
,
Michel Beaugrand
Journal of Hepatology
Article
2008
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet
,
Jordi Bruix
Hepatology
Article
2021
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Monica Margoni
,
Paolo Preziosa
,
Massimo Filippi
,
Maria A. Rocca
Discussion(0)
No comments yet. Be the first to comment.